Insmed (INSM) Share-based Compensation (2010 - 2026)

Insmed's Share-based Compensation history runs 17 years deep, the most recent figure standing at $45.8 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 16.54% year-over-year to $45.8 million in Q1 2026; TTM through Mar 2026 was $159.2 million, a 38.86% increase from a year earlier, with the FY2025 full-year figure at $152.7 million, up 57.7% from the prior year.
• Share-based Compensation improved to $45.8 million in Q1 2026 per INSM's latest filing, from $39.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $45.8 million in Q1 2026 and bottomed at $12.8 million in Q1 2022.
• The 5-year median for Share-based Compensation is $21.4 million (2024), against an average of $25.2 million.
• Across the five-year window, Share-based Compensation surged 84.56% in 2025 and grew 16.54% in 2026, its largest moves.
• Year by year, Share-based Compensation stood at $15.0 million in 2022, then surged by 33.67% to $20.0 million in 2023, then soared by 32.88% to $26.6 million in 2024, then surged by 47.02% to $39.0 million in 2025, then gained by 17.2% to $45.8 million in 2026.
• Per Business Quant, the three latest INSM Share-based Compensation figures stand at $45.8 million (Q1 2026), $39.0 million (Q4 2025), and $31.4 million (Q3 2025).